Literature DB >> 10753166

Using anticoagulation or aspirin to prevent stroke. Research was methodologically flawed.

S J Ellis, R Hans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10753166      PMCID： PMC1117881          DOI： 10.1136/bmj.320.7240.1008

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  17 in total

1.  Atrial fibrillation in elderly patients: prevalence and comorbidity in general practice.

Authors:  M Langenberg; B S Hellemons; J W van Ree; F Vermeer; J Lodder; H J Schouten; J A Knottnerus
Journal:  BMJ       Date:  1996-12-14

2.  The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators.

Authors: 
Journal:  Arch Intern Med       Date:  1997-06-09

3.  A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project.

Authors:  G Y Lip; D J Golding; M Nazir; D G Beevers; D L Child; R I Fletcher
Journal:  Br J Gen Pract       Date:  1997-05       Impact factor: 5.386

4.  Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial.

Authors: 
Journal:  Lancet       Date:  1996-09-07       Impact factor: 79.321

5.  Use of antithrombotic measures for stroke prevention in atrial fibrillation.

Authors:  I Perez; A Melbourn; L Kalra
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

6.  Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Authors:  P Petersen; G Boysen; J Godtfredsen; E D Andersen; B Andersen
Journal:  Lancet       Date:  1989-01-28       Impact factor: 79.321

7.  Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

Authors:  F J van der Meer; F R Rosendaal; J P Vandenbroucke; E Briët
Journal:  Arch Intern Med       Date:  1993-07-12

8.  Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

Authors: 
Journal:  Arch Intern Med       Date:  1994-07-11

9.  Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.

Authors: 
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

10.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13
View more
  2 in total

1.  Long term anticoagulation or antiplatelet treatment. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation.

Authors:  J G Cleland; G C Kaye
Journal:  BMJ       Date:  2001-07-28

2.  Care is required with cost effectiveness approach.

Authors:  C Cates
Journal:  BMJ       Date:  2000-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.